Treating short stature associated with Turner syndrome
Your endocrinologist can tell you about growth hormone therapy and how it can help improve the short stature associated with TS. Growth hormone is produced by the pituitary gland, sometimes called the "master gland" because it controls when several hormones are made and released by other parts of the body.
TS patients don't usually need to be tested for a growth hormone deficiency because their growth hormone levels are normal. But poor long bone growth and spinal column growth lead to short stature and growth failure in nearly 100% of TS patients.
One reason for poor growth is that one of the genes necessary for bone growth is missing. Nutropin therapy may partially make up for the missing genetic material to improve bone growth.
Genentech products approved for the treatment of short stature associated with Turner syndrome
Nutropin AQ and Nutropin are approved for the long-term treatment of short stature due to TS.To learn more, click on the names of the products below—and be sure to discuss them with your healthcare provider.
Nutropin AQ Pen 10 for use with Nutropin AQ Pen 10 Cartridge: The latest innovation from Genentech's growth hormone product line, the Nutropin AQ Pen 10 offers simple delivery of Nutropin AQ, convenient transport, and enhanced safety features. Nutropin AQ Pen 10 is available in the U.S. by prescription only.
Nutropin AQ: A liquid GH that is premixed and ready for immediate injection. Unlike lyophilized (powdered) forms of GH, no mixing is necessary. Nutropin AQ makes GH therapy easier by eliminating about half the steps required to prepare lyophilized GH.
Nutropin: A lyophilized powder formulation that is reconstituted, or mixed, with Bacteriostatic water prior to an injection.
